Toll Free: 1-888-928-9744

Global Commercializing Biomarkers Market Professional Survey Report 2017

Published: May, 2017 | Pages: 117 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report studies Commercializing Biomarkers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

•	Roche
•	Dako (Agilent Technologies)
•	Merck
•	BD
•	Abbott
•	Genesys Biolabs (20/20GeneSystems)
•	Affymetrix
•	Agendia
•	ALMAC
•	Arrayit
•	Biocartic
•	BG Medicine
•	KEGG EXPRESSION Database
•	Thermo Fisher
•	BGI

By types, the market can be split into

•	Consumables
•	Services
•	Software

By Application, the market can be split into

•	Oncology
•	Cardiology
•	Neurology
•	Others

By Regions, this report covers (we can add the regions/countries as you want)

•	North America
•	China
•	Europe
•	Southeast Asia
•	Japan
•	India

If you have any special requirements, please let us know and we will offer you the report as you want.
 Table of Contents

Global Commercializing Biomarkers Market Professional Survey Report 2017

1 Industry Overview of Commercializing Biomarkers
    1.1 Definition and Specifications of Commercializing Biomarkers
        1.1.1 Definition of Commercializing Biomarkers
        1.1.2 Specifications of Commercializing Biomarkers
    1.2 Classification of Commercializing Biomarkers
        1.2.1 Consumables
        1.2.2 Services
        1.2.3 Software
    1.3 Applications of Commercializing Biomarkers
        1.3.1 Oncology
        1.3.2 Cardiology
        1.3.3 Neurology
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers
    2.3 Manufacturing Process Analysis of Commercializing Biomarkers
    2.4 Industry Chain Structure of Commercializing Biomarkers

3 Technical Data and Manufacturing Plants Analysis of Commercializing Biomarkers
    3.1 Capacity and Commercial Production Date of Global Commercializing Biomarkers Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Commercializing Biomarkers Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Commercializing Biomarkers Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Commercializing Biomarkers Major Manufacturers in 2016

4 Global Commercializing Biomarkers Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Commercializing Biomarkers Capacity and Growth Rate Analysis
        4.2.2 2016 Commercializing Biomarkers Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Commercializing Biomarkers Sales and Growth Rate Analysis
        4.3.2 2016 Commercializing Biomarkers Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Commercializing Biomarkers Sales Price
        4.4.2 2016 Commercializing Biomarkers Sales Price Analysis (Company Segment)

5 Commercializing Biomarkers Regional Market Analysis
    5.1 North America Commercializing Biomarkers Market Analysis
        5.1.1 North America Commercializing Biomarkers Market Overview
        5.1.2 North America 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.1.4 North America 2016 Commercializing Biomarkers Market Share Analysis
    5.2 China Commercializing Biomarkers Market Analysis
        5.2.1 China Commercializing Biomarkers Market Overview
        5.2.2 China 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.2.4 China 2016 Commercializing Biomarkers Market Share Analysis
    5.3 Europe Commercializing Biomarkers Market Analysis
        5.3.1 Europe Commercializing Biomarkers Market Overview
        5.3.2 Europe 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.3.4 Europe 2016 Commercializing Biomarkers Market Share Analysis
    5.4 Southeast Asia Commercializing Biomarkers Market Analysis
        5.4.1 Southeast Asia Commercializing Biomarkers Market Overview
        5.4.2 Southeast Asia 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.4.4 Southeast Asia 2016 Commercializing Biomarkers Market Share Analysis
    5.5 Japan Commercializing Biomarkers Market Analysis
        5.5.1 Japan Commercializing Biomarkers Market Overview
        5.5.2 Japan 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.5.4 Japan 2016 Commercializing Biomarkers Market Share Analysis
    5.6 India Commercializing Biomarkers Market Analysis
        5.6.1 India Commercializing Biomarkers Market Overview
        5.6.2 India 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Commercializing Biomarkers Sales Price Analysis
        5.6.4 India 2016 Commercializing Biomarkers Market Share Analysis

6 Global 2012-2017E Commercializing Biomarkers Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Commercializing Biomarkers Sales by Type
    6.2 Different Types of Commercializing Biomarkers Product Interview Price Analysis
    6.3 Different Types of Commercializing Biomarkers Product Driving Factors Analysis
        6.3.1 Consumables of Commercializing Biomarkers Growth Driving Factor Analysis
        6.3.2 Services of Commercializing Biomarkers Growth Driving Factor Analysis
        6.3.3 Software of Commercializing Biomarkers Growth Driving Factor Analysis

7 Global 2012-2017E Commercializing Biomarkers Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Commercializing Biomarkers Consumption by Application
    7.2 Different Application of Commercializing Biomarkers Product Interview Price Analysis
    7.3 Different Application of Commercializing Biomarkers Product Driving Factors Analysis
        7.3.1 Oncology of Commercializing Biomarkers Growth Driving Factor Analysis
        7.3.2 Cardiology of Commercializing Biomarkers Growth Driving Factor Analysis
        7.3.3 Neurology of Commercializing Biomarkers Growth Driving Factor Analysis
        7.3.4 Others of Commercializing Biomarkers Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Commercializing Biomarkers
    8.1 Roche
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Roche 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Roche 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.2 Dako (Agilent Technologies)
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Dako (Agilent Technologies) 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Dako (Agilent Technologies) 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.3 Merck
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Merck 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Merck 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.4 BD
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 BD 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 BD 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.5 Abbott
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Abbott 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Abbott 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.6 Genesys Biolabs (20/20GeneSystems)
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Genesys Biolabs (20/20GeneSystems) 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Genesys Biolabs (20/20GeneSystems) 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.7 Affymetrix
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Affymetrix 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Affymetrix 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.8 Agendia
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Agendia 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Agendia 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.9 ALMAC
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 ALMAC 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 ALMAC 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.10 Arrayit
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Arrayit 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Arrayit 2016 Commercializing Biomarkers Business Region Distribution Analysis
    8.11 Biocartic
    8.12 BG Medicine
    8.13 KEGG EXPRESSION Database
    8.14 Thermo Fisher
    8.15 BGI

9 Development Trend of Analysis of Commercializing Biomarkers Market
    9.1 Global Commercializing Biomarkers Market Trend Analysis
        9.1.1 Global 2017-2022 Commercializing Biomarkers Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Commercializing Biomarkers Sales Price Forecast
    9.2 Commercializing Biomarkers Regional Market Trend
        9.2.1 North America 2017-2022 Commercializing Biomarkers Consumption Forecast
        9.2.2 China 2017-2022 Commercializing Biomarkers Consumption Forecast
        9.2.3 Europe 2017-2022 Commercializing Biomarkers Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Commercializing Biomarkers Consumption Forecast
        9.2.5 Japan 2017-2022 Commercializing Biomarkers Consumption Forecast
        9.2.6 India 2017-2022 Commercializing Biomarkers Consumption Forecast
    9.3 Commercializing Biomarkers Market Trend (Product Type)
    9.4 Commercializing Biomarkers Market Trend (Application)

10 Commercializing Biomarkers Marketing Type Analysis
    10.1 Commercializing Biomarkers Regional Marketing Type Analysis
    10.2 Commercializing Biomarkers International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Commercializing Biomarkers by Region
    10.4 Commercializing Biomarkers Supply Chain Analysis

11 Consumers Analysis of Commercializing Biomarkers
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
 
12 Conclusion of the Global Commercializing Biomarkers Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures

    Figure Picture of Commercializing Biomarkers
    Table Product Specifications of Commercializing Biomarkers
    Table Classification of Commercializing Biomarkers
    Figure Global Production Market Share of Commercializing Biomarkers by Type in 2016
    Figure Consumables Picture
    Table Major Manufacturers of Consumables
    Figure Services Picture
    Table Major Manufacturers of Services
    Figure Software Picture
    Table Major Manufacturers of Software
    Table Applications of Commercializing Biomarkers
    Figure Global Consumption Volume Market Share of Commercializing Biomarkers by Application in 2016
    Figure Oncology Examples
    Table Major Consumers of Oncology
    Figure Cardiology Examples
    Table Major Consumers of Cardiology
    Figure Neurology Examples
    Table Major Consumers of Neurology
    Figure Others Examples
    Table Major Consumers of Others
    Figure Market Share of Commercializing Biomarkers by Regions
    Figure North America Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Figure China Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Figure Europe Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Figure Japan Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Figure India Commercializing Biomarkers Market Size (Million USD) (2012-2022)
    Table Commercializing Biomarkers Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Commercializing Biomarkers in 2016
    Figure Manufacturing Process Analysis of Commercializing Biomarkers
    Figure Industry Chain Structure of Commercializing Biomarkers
    Table Capacity and Commercial Production Date of Global Commercializing Biomarkers Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Commercializing Biomarkers Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Commercializing Biomarkers Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Commercializing Biomarkers Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Commercializing Biomarkers 2012-2017
    Figure Global 2012-2017E Commercializing Biomarkers Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Commercializing Biomarkers Market Size (Value) and Growth Rate
    Table 2012-2017E Global Commercializing Biomarkers Capacity and Growth Rate
    Table 2016 Global Commercializing Biomarkers Capacity (K Units) List (Company Segment)
    Table 2012-2017E Global Commercializing Biomarkers Sales (K Units) and Growth Rate
    Table 2016 Global Commercializing Biomarkers Sales (K Units) List (Company Segment)
    Table 2012-2017E Global Commercializing Biomarkers Sales Price (USD/Unit)
    Table 2016 Global Commercializing Biomarkers Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E 
    Figure North America 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit)
    Figure North America 2016 Commercializing Biomarkers Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E 
    Figure China 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit) 
    Figure China 2016 Commercializing Biomarkers Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E
    Figure Europe 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit)
    Figure Europe 2016 Commercializing Biomarkers Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E
    Figure Southeast Asia 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit)
    Figure Southeast Asia 2016 Commercializing Biomarkers Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E
    Figure Japan 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit)
    Figure Japan 2016 Commercializing Biomarkers Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Commercializing Biomarkers 2012-2017E
    Figure India 2012-2017E Commercializing Biomarkers Sales Price (USD/Unit)
    Figure India 2016 Commercializing Biomarkers Sales Market Share
    Table Global 2012-2017E Commercializing Biomarkers Sales (K Units) by Type
    Table Different Types Commercializing Biomarkers Product Interview Price
    Table Global 2012-2017E Commercializing Biomarkers Sales (K Units) by Application
    Table Different Application Commercializing Biomarkers Product Interview Price
    Table Roche Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Roche Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Roche Commercializing Biomarkers Business Region Distribution
    Table Dako (Agilent Technologies) Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Dako (Agilent Technologies) Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Dako (Agilent Technologies) Commercializing Biomarkers Business Region Distribution
    Table Merck Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Merck Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Merck Commercializing Biomarkers Business Region Distribution
    Table BD Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 BD Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 BD Commercializing Biomarkers Business Region Distribution
    Table Abbott Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Abbott Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Abbott Commercializing Biomarkers Business Region Distribution
    Table Genesys Biolabs (20/20GeneSystems) Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Business Region Distribution
    Table Affymetrix Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Affymetrix Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Affymetrix Commercializing Biomarkers Business Region Distribution
    Table Agendia Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Agendia Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Agendia Commercializing Biomarkers Business Region Distribution
    Table ALMAC Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 ALMAC Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 ALMAC Commercializing Biomarkers Business Region Distribution
    Table Arrayit Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Arrayit Commercializing Biomarkers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Arrayit Commercializing Biomarkers Business Region Distribution
    Table Biocartic Information List
    Table BG Medicine Information List
    Table KEGG EXPRESSION Database Information List
    Table Thermo Fisher Information List
    Table BGI Information List
    Figure Global 2017-2022 Commercializing Biomarkers Market Size (K Units) and Growth Rate Forecast
    Figure Global 2017-2022 Commercializing Biomarkers Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Commercializing Biomarkers Sales Price (USD/Unit) Forecast
    Figure North America 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2017-2022 Commercializing Biomarkers Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Commercializing Biomarkers by Type 2017-2022
    Table Global Consumption Volume (K Units) of Commercializing Biomarkers by Application 2017-2022
    Table Traders or Distributors with Contact Information of Commercializing Biomarkers by Region

 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3500
Multi User - US $7000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify